cavinton-instruction
cavinton-instruction

CAVINTON ® (Vinpocetine)

Clear
Bulk deal
Quantity Discount Discounted price
2 5% -
3 8% -
4 10% -
5 12% -
6 14% -
7 16% -
8 + 18% -
Bulk pricing will be applied to package:

Vinpocetine (ethyl apovincaminate) is a nootropic drug obtained from vincamine, an alkaloid of the Vinca minor plant. You now can buy Vinpocetine from CosmicNootopic!

Vinpocetine was discovered in the 1960s in Hungary and it has a history of medicinal use since 1978. Currently, it is known under the brand name Cavinton, which is a #2 bestselling drug of one of the largest European pharmaceutical companies, Gedeon Richter.

Besides wide usage in medicine, ethyl apovincaminate is often seen in nootropic supplements stacks available on the US market. It is also a component of a combination drug Vinpotropile, widely used in Russia.

Vinpocetine is a cerebral vasodilator, thus its primary pharmacological effect is the improvement of cerebral blood flow, and the primary clinical use is the treatment of cerebrovascular disorders such as strokes and atherosclerosis. The vasodilatory action of Vinpocetine is mediated by smooth muscle relaxation and a decrease in blood viscosity.

According to clinical trials and anecdotal experiences, you can buy Vinpocetine to relieve tinnitus. This also applies to another cerebral vasodilator of herbal origin, Bilobil (Ginkgo Biloba extract). It is also suggested that Cavinton (Vinpocetine) has only minor side effects.

Besides the beneficial effect on blood flow, Vinpocetine was shown to have pronounced neuroprotective benefits. Vinpocetine inhibits voltage-gated sodium channels with the blocking potency comparable to that of Phenytoin, an anticonvulsant drug.

Produced by Gedeon Richter, Hungary.

Dosage and administration

Dosage: 5–10 mg, 2-3 times per day. Course: 3–8 weeks. Before discontinuing taper the dose down.

It is possible to have 2-3 courses over 1 year period.

Contraindications

  • Hypersensitivity;
  • The acute phase of hemorrhagic stroke;
  • Ischemic heart disease or acute arrhythmia;
  • Pregnancy and lactation;
  • Lactose intolerance;
  • Age below 18 years.

 

Side effects

Vinpocetine is usually well-tolerated and side effects are unlikely to occur. However, they may include:

  • Labile/low blood pressure;
  • Tachycardia;
  • Extrasystole;
  • Sleepiness/insomnia;
  • Vertigo;
  • Drowsiness;
  • Sweating;
  • Dry mouth;
  • Nausea;
  • Heartburn;
  • Allergic reactions.

 

Drug interaction

Vinpocetine does not interact with beta-blockers (Cloranolol, Pindolol), Clopamide, Glibenclamide, Digoxin, Acenocoumarol, Hydrochlorothiazide and Imipramine. The drug potentiates the hypotensive effect of Methyldopa.

Despite the lack of data regarding interactions with drugs that have central, antiarrhythmic and anticoagulant actions, Vinpocetine should be used cautiously if coadministered with them.

Manufacturer

Gedeon Richter, Hungary.

  1. Dutov et al (1986) Use of cavinton in epilepsy https://www.ncbi.nlm.nih.gov/pubmed/3751419
  2. Burtsev et al (1988) Effectiveness of using cavinton in patients of different ages with chronic forms of cerebrovascular diseases (clinico-rheographic research) https://www.ncbi.nlm.nih.gov/pubmed/3364094
  3. B Kiss, E Karpati (1996) Mechanism of action of vinpocetine https://www.ncbi.nlm.nih.gov/pubmed/9082841
  4. Szakall et al (1998) Cerebral effects of a single dose of intravenous vinpocetine in chronic stroke patients: a PET study https://www.ncbi.nlm.nih.gov/pubmed/9780850
  5. S Szatmari, P Whitehouse (2003) Vinpocetine for cognitive impairment and dementia https://www.ncbi.nlm.nih.gov/pubmed/12535455
  6. Protasov et al (2006) Cavinton forte treatment of cerebral vascular insufficiency in patients with coronary heart disease and arterial hypertension https://www.ncbi.nlm.nih.gov/pubmed/16921716
  7. Nyakas et al (2009) Neuroprotective effects of vinpocetine and its major metabolite cis-apovincaminic acid on NMDA-induced neurotoxicity in a rat entorhinal cortex lesion model https://www.ncbi.nlm.nih.gov/pubmed/19492990
  8. Afon’kin et al (2009) The new scheme of cavinton application to the treatment of chronic neurosensory loss of hearing https://www.ncbi.nlm.nih.gov/pubmed/20081798
  9. E Chukanova (2010) Efficacy of cavinton in the treatment of patients with chronic blood flow insufficiency. Russian multicenter clinical-epidemiological program “CALIPSO” https://www.ncbi.nlm.nih.gov/pubmed/21311488
  10. Jeon et al (2010) Vinpocetine inhibits NF-κB–dependent inflammation via an IKK-dependent but PDE-independent mechanism https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2906898/
  11. Patyar et al (2011) Role of vinpocetine in cerebrovascular diseases https://www.ncbi.nlm.nih.gov/pubmed/21857073
  12. Cai et al (2013) Vinpocetine Attenuates Lipid Accumulation and Atherosclerosis Formation https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3682500/
  13. A Ogunrin (2014) Effect of Vinpocetine (Cognitol™) on Cognitive Performances of a Nigerian Population https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4160700/
  14. Alkuraishy et al (2014) Vinpocetine and Pyritinol: A New Model for Blood Rheological Modulation in Cerebrovascular Disorders—A Randomized Controlled Clinical Study https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4274818/
  15. Ruiz-Miyazawa et al (2015) Vinpocetine Reduces Carrageenan-Induced Inflammatory Hyperalgesia in Mice by Inhibiting Oxidative Stress, Cytokine Production and NF-κB Activation in the Paw and Spinal Cord
  16. Manda et al (2015) Studies on Pharmacokinetic Drug Interaction Potential of Vinpocetine https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5533163/
  17. Lee et al (2015) Vinpocetine Inhibits Streptococcus pneumoniae–Induced Upregulation of Mucin MUC5AC Expression via Induction of MKP-1 Phosphatase in the Pathogenesis of Otitis Media https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4456630/
  18. Wu et al (2017) Vinpocetine Attenuates Pathological Cardiac Remodeling by Inhibiting Cardiac Hypertrophy and Fibrosis https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5663637/
  19. Zhang et al (2018) An update on Vinpocetine: New discoveries and clinical implications https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5766389/

Related products

CYTOGENS (Synthesized Peptides)

$ 35.00$ 70.00

CYTOGENS (SYNTHESIZED PEPTIDES) are physiologically active short peptides; they are synthesized combinations of 2-3 amino acids. Cytogens have a faster action compared to extract peptides - CYTOMAX peptides. By reducing peptide deficiency within organs and restoring protein synthesis, Cytogens regulate work and functionality of organs and slow down the ageing process. These peptides can be easily combined with other supplements and medicines and should be used in addition to conventional medical treatment.

BBS Сosmetic Placental Peptide Extract is a substance with a cosmetic properties. It contains hyaluronic acid, which binds and holds free fluid, and together with linoleic acid, another component of the product, prevents its loss. Regular use of this cosmetic product makes the skin resilient and supple.

Aralia is a well-known gentle adaptogenic tonic herb popular for its wide range of pharmacological properties. It is used to treat physical and mental fatigue, asthenic syndrome, arterial hypotension, decreased sex drive, mental breakdown, depression, enuresis, radiation sickness and metabolic disorders. ThisВ herbal remedy can also help to recover from craniocerebral injury, contusion, meningitis, post-infectious arachnoiditis and ARVI (in the complex therapy).

ADAPTOL ® (Mebicar)

$ 18.00$ 46.00

Mebicar (or tetramethylglycoluril) is an anxiolytic medication that works on the serotonergic system: taken in small doses it increases the effect of tryptophan, which is a precursor to serotonin. Mebicar purportedly has anti-anxiety properties. It is also used to aid smoking cessation and in the treatment of ADHD symptoms. Mebicar decreases the brain noradrenaline level, exerts no effect on the dopaminergic systems, increases the brain serotonin level, and does not elicit cholinolytic action.